MB, Levis & Associates’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-197
Closed -$4.56K 280
2023
Q3
$4.56K Buy
197
+2
+1% +$47 ﹤0.01% 218
2023
Q2
$4.58K Buy
195
+2
+1% +$47 ﹤0.01% 221
2023
Q1
$4.61K Buy
193
+1
+0.5% +$24 ﹤0.01% 224
2022
Q4
$4.49K Buy
+192
New +$4.45K ﹤0.01% 211

Other funds holding IBDS

MB, Levis & Associates's IBDS Position: Q4 2023 in Review

MB, Levis & Associates sold out of iShares iBonds Dec 2027 Term Corporate ETF (IBDS) in Q4 2023, closing a stake of 197 shares — an estimated $4.56K sold.

MB, Levis & Associates first reported a position in IBDS in Q4 2022 and held it in 4 quarters. The position peaked at $4.61K in Q1 2023. 270 funds tracked by Wall St. Rank hold IBDS as of Q4 2023.

  • MB, Levis & Associates reported no remaining iShares iBonds Dec 2027 Term Corporate ETF position as of Q4 2023 after selling out during the quarter.
  • MB, Levis & Associates sold 197 iShares iBonds Dec 2027 Term Corporate ETF shares in Q4 2023, an estimated $4.56K.
  • MB, Levis & Associates first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q4 2022 and held it in 4 quarters.
  • MB, Levis & Associates's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $4.61K in Q1 2023.
  • 270 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q4 2023.

Based on MB, Levis & Associates's 13F filing for Q4 2023, filed 7 May 2025.